← Back to Clinical Trials
Recruiting NCT06638645

NCT06638645 Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06638645
Status Recruiting
Phase
Sponsor University Hospital, Ghent
Condition Minimally Invasive Surgical Procedures
Study Type OBSERVATIONAL
Enrollment 140 participants
Start Date 2024-11-12
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
VATS/RATS anatomical lung resection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 140 participants in total. It began in 2024-11-12 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.

Eligibility Criteria

Inclusion Criteria: * Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy) * Informed consent obtained pre-operatively * Age 18 years or older Exclusion Criteria: * Patients younger than 18 years old * Traumatic event as indication for lung resection * Non-anatomical lung resections * Thoracotomy * Patients already hospitalized for other pathologies, pre-existent and not related to the lung surgery * Urgent/emergency procedures

Contact & Investigator

Central Contact

Liesbeth Desender, MD, PhD

✉ Liesbeth.Desender@uzgent.be

📞 3293326148

Frequently Asked Questions

Who can join the NCT06638645 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Minimally Invasive Surgical Procedures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06638645 currently recruiting?

Yes, NCT06638645 is actively recruiting participants. Contact the research team at Liesbeth.Desender@uzgent.be for enrollment information.

Where is the NCT06638645 trial being conducted?

This trial is being conducted at Bruges, Belgium, Ghent, Belgium.

Who is sponsoring the NCT06638645 clinical trial?

NCT06638645 is sponsored by University Hospital, Ghent. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology